LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹111 Cr | ₹93 Cr | ₹194 Cr | ₹86 Cr | ₹61 Cr |
What is the latest Revenue of LYKA LABS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹111 Cr |
| Mar2024 | ₹93 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹86 Cr |
| Mar2021 | ₹61 Cr |
How is Revenue of LYKA LABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹111 Cr | 19.47 | |
| Mar2024 | ₹93 Cr | -52.05 | |
| Mar2023 | ₹194 Cr | 125.02 | |
| Mar2022 | ₹86 Cr | 40.27 | |
| Mar2021 | ₹61 Cr | - | |
Compare Revenue of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹237.7 Cr | -5.3% | -4.2% | -39.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -5.3% |
-4.2% |
-39.9% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses